Fate Therapeutics
Cell & Gene Therapy · Oncology Therapeutics

Fate Therapeutics news and milestones

Fate Therapeutics: 40 headlines on record, 25 headlines in the last 90 days. Its story counts 3 milestones.

Data updated Nov 18, 2026 · Back to the company report
40Headlines
25In 90 days
3Milestones

Headlines

Oct 72026
News · Fate Therapeutics stock adds two Q4 conference dates
Fate Therapeutics stock closed at USD 2.43 on October 5, 2026, while analysts set an average target of USD 5.90. Q2 revenue reached USD 2.08 million.
Oct 62026
News · Fate Therapeutics stock gained 4.74 percent on October 5
Fate Therapeutics stock gained after the company granted 62,900 options at USD 2.30 on October 1. Second-quarter revenue reached USD 2.08 million versus USD 1.94 million consensus.
Oct 12026
Blog
The post Providence Medical Foundation appeared first on Fate Therapeutics.
Oct 12026
News · markets.businessinsider.com
SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bri...
Oct 12026
Blog
The post University of Southern California appeared first on Fate Therapeutics.
Oct 12026
Blog
The post UC San Diego Moores Cancer Center appeared first on Fate Therapeutics.
Oct 12026
Blog
The post University of Nebraska Medical Center appeared first on Fate Therapeutics.
Oct 12026
Blog
The post Miami Dermatology and Laser Research appeared first on Fate Therapeutics.
Oct 12026
Blog
The post University of Florida Clinical Research Center appeared first on Fate Therapeutics.
Oct 12026
Blog
The post University of California San Francisco appeared first on Fate Therapeutics.
Oct 12026
Blog
The post University of California Irvine appeared first on Fate Therapeutics.
Oct 12026
Blog
The post Kaiser Permanente Fontana appeared first on Fate Therapeutics.
Oct 12026
Blog
The post The University of Texas Southwestern Medical Center appeared first on Fate Therapeutics.
Oct 12026
Blog
The post Cross Creek Medical Clinic appeared first on Fate Therapeutics.
Oct 12026
Blog
The post Nicklaus Children's Hospital appeared first on Fate Therapeutics.
Oct 12026
Blog
The post Wallace Rheumatic Studies Center appeared first on Fate Therapeutics.
Sep 292026
Blog
Rheumatoid arthritis (RA) is a long-term autoimmune disease that causes the immune system to mistakenly attack the lining of the joints, leading to pain, swelling, stiffness, and…
Sep 282026
News · pharmabiz.com
Fate Therapeutics receives California Institute for Regenerative Medicine $15.0 mn grant through its CLIN2 programme to advance RECLAIM-LN
Sep 252026
News · YahooFinance
$15.0 Million Award to Support Advancement of RECLAIM-LN, a Phase 2 Potentially Registrational Trial of FT819 Off-the-Shelf CAR T-Cell Therapy in Lupus Nephritis CLIN2 Grant is a…
Sep 212026
Blog
The post Safety and Efficacy of an Off-the-Shelf Anti-CD19 CAR T-Cell Therapy With Reduced Conditioning in SLE Supporting Same-Day Discharge appeared first on Fate Therapeutics.
Sep 212026
Blog
The post Off-the-Shelf Dual-CAR T-Cell Therapy: Targeting B and T Cells in Autoimmune Disease Without Preconditioning appeared first on Fate Therapeutics.
Sources: the outlets named on each headline, each story once

Milestones

Each milestone is dated by its source: registers, filings, the press

How to cite

Fate Therapeutics, News. Alion, Nov 18, 2026. https://alion.io/company/fatetherapeutics/news

.json · .md · CC BY-SA 4.0